跳至主要内容
临床试验/ISRCTN92125844
ISRCTN92125844已完成不适用

Acupuncture as a disease modifying therapy for treatment in remission stage of neuromyelitis optics spectrum disorders: a prospective clinical randomised parallel trial

Beijing Traditional Chinese Medical Hospital Affiliated to Capital Medical University0 个研究点目标入组 40 人开始时间: 2016年12月22日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Diagnosis of neuromyelitis optics spectrum disorders in accordance with NMOSDs diagnostic criteria established by the international panel for NMO diagnosis (IPND) in 2015.
  • 2. In remission stage (no acute progress, no corticosteroid therapy or immunoglobulin therapy, plasma exchange, stable condition without relapse signs)
  • 3. Age of 18-75 years old
  • 4. EDSS score less than 5
  • 5. No other treatment with immunosuppressive drugs within 6 months or no other immunosuppressive drugs other than azathioprine
  • 6. Provision of informed consent

排除标准

  • 1. Oral azathioprine intolerant patients
  • 2. History of severe allergies
  • 3. Those who can not tolerate acupuncture
  • 4. Clinically significant history of disease, blood disease, endocrine, metabolism, liver, lung, urinary system, nervous system, skin disease, other major primary disease and psychiatric disease
  • 5. Malignant tumor
  • 6. B type hepatitis
  • 7. Pregnancy or lactation

研究者

发起方
Beijing Traditional Chinese Medical Hospital Affiliated to Capital Medical University

相似试验